Results 81 to 90 of about 750,934 (136)

PD-1 inhibitors for oesophageal cancer [PDF]

Nature Reviews Gastroenterology & Hepatology, 2019
openaire   +2 more sources

Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors. [PDF]

Biomark Res
Chen S, Hu Y, Cheng H, Guo S, Han Y, Li K.   +5 more
europepmc   +1 more source

Cordyceps sinensis enhances the efficacy of anti-PD-1 immunotherapy in Lewis lung adenocarcinoma. [PDF]

Sci Rep
Liu Y, Gao Y, Suonanlamao, Ma Y, Xiao Y, Wei L, Zhou W.   +6 more
europepmc   +1 more source

PD-1 Expression Promotes Immune Evasion in B-ALL. [PDF]

Hematol Rep
Casado-García A, García-Aguilera G, Pozo J, Oak N, Barrena S, Ruiz-Corzo B, Lalchandani J, Chamorro-Vera A, Castillo-Robleda A, Soriano B, Alemán-Arteaga S, Sánchez EG, Martínez-Cano J, López-Álvarez de Neyra A, Somoza-Cotillas P, Blanco O, Riesco S, Prieto-Matos P, García Criado FJ, García Cenador MB, Cobaleda C, Vicente-Dueñas C, Nichols KE, Orfao A, Ramírez-Orellana M, Sánchez-García I.   +25 more
europepmc   +1 more source

Neoadjuvant PD-1 blockade in NSCLC [PDF]

Nature Reviews Clinical Oncology, 2018
openaire   +2 more sources

Dual blockades of TIM-3 and PD-1 effectively prevent hyper-progression and enhance the efficacy of anti-PD-1 therapy in high-grade serous ovarian cancer. [PDF]

Cell Death Dis
Li J, Zhou Y, Song Y, Dai G, Li X, Sun Y, Wang J, Wei R, Li F, Xi L.   +9 more
europepmc   +1 more source

PD-1,CTLA-4

Okayama Igakkai Zasshi (Journal of Okayama Medical Association), 2015
openaire   +2 more sources

Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis. [PDF]

Redox Biol
Yang F, Huang W, Meng Z, Liu M, Lyu A, Mauro C, Cheung KCP.   +6 more
europepmc   +1 more source

Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma. [PDF]

Mol Cancer
Zeng A, Chen H, Luo T, Chen W, Song Y, Xu Y, Chen Z, Tang Q, Zhu X, Deng C, Xu H, Wang A, Wu H, Song G, Lu J, Wang J.   +15 more
europepmc   +1 more source

Prevalence of PD-1 Inhibitor-Associated Peripheral Neuropathy: A Retrospective Cohort Study. [PDF]

Life (Basel)
Ganji-Angirekula S, Segada NW, Hasan P, Grace PM, Wang J, Sun X, Javed S.   +6 more
europepmc   +1 more source